Navigation Links
Study finds evolution doesn't always favor bigger animals

Biologists have long believed that bigger is better when it comes to body size, since many lineages of animals, from horses to dinosaurs, have evolved into larger species over time.

But a study published this week by two biologists at the University of California, San Diego in an early online edition of the Proceedings of the National Academy of Sciences suggests that maxim, known as "Cope's Rule," may be only partly true.

The scientists found that populations of tiny crustaceans retrieved from deep-sea sediments over the past 40 million years grew bigger and evolved into larger species, as might be predicted from Cope's Rule. However, the changes in the sizes of these clam-like crustaceans commonly known as ostracodes --from the genus Poseidonamicus -- increased only when the global ocean temperature cooled. When temperatures remained stable, not much happened to body size.

"These data show a very nice correlation between temperature and body size," said Kaustuv Roy, a professor of biology at UCSD and a coauthor of the paper.

"Although not the most glamorous of fossils, deep-sea ostracodes are very useful for this question because they have a rich fossil record, which allows us to reconstruct the evolution of body size in great detail," said Gene Hunt, who designed and conducted the study while postdoctoral fellow at UCSD.

"Scientists have been interested in how body size evolves for a long time, but there is a lot of uncertainty about what factors are most important in determining whether animals get bigger or smaller over time," added Hunt, now a curator at the National Museum of Natural History in Washington, DC.

The two scientists said their data suggest that Cope's Rule--named for Edward Cope, a 19 th century American paleontologist who claimed the fossil record showed that lineages became larger over time--may simply be an evolutionary manifestation of Bergmann's Rule, which holds that animals increase in m
'"/>

Source:University of California - San Diego


Page: 1 2 3

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works

Post Your Comments:
(Date:11/23/2009)..., CINCINNATINew research presents strong evidence...ure to both outdoor traffic-related pollution and ...ngs than one or the other exposure alone. , En... Cincinnati (UC) College of Medicine have shown th...-related particles and indoor endotoxin during ear...
(Date:11/23/2009)..., TORONTO, November 23, 2009 - The time of day ...rding to a new paper produced by a research team l...ronto Scarborough,s vice-principal for research an... biology at the St. George campus. , Capitaliz... the poplar tree, the research team examined how p...
(Date:11/23/2009)..., Farmington, CT Current research suggests that ...disease. The related report by Nichols et al, "Un...t a New Class of TLR2 Ligands Capable of Enhancing... of The American Journal of Pathology . , Multi...tem attacks the brain and spinal cord, affects nea...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Martek to Present at Upcoming Canaccord Adams Conference 52983 1Mathematical modeling predicts response to Herceptin 52980 1Mathematical modeling predicts response to Herceptin 52980 2Northwest Hospital Introduces Hyperbaric Oxygen Therapy 52978 1Northwest Hospital Introduces Hyperbaric Oxygen Therapy 52978 2
... CORVALLIS, Ore. Contrary to 40 years of convent...y in the journal Nature suggests that old growth...ue to absorb carbon dioxide from the atmosphere an...r, these old growth forests around the world are n...en considered of no significance in the national "...
... VIRGINIA KEY, Fla. -- The precise timing of the ...ring the past 4.5 billion years has been a subject...rincipal indicator of the amount of organic carbon...d is the ratio of the less abundant isotope of car...lants preferentially incorporate 12C, during perio...
... , Researchers studying a critical stage of pregna...e found a protein that is vital to the growth of n...this protein, which is produced in higher quantiti...kely to survive. , This is the first study to det...rogen spurs cell differentiation and blood-vessel ...
Other Biology News:Old growth forests are valuable carbon sinks 2Old growth forests are valuable carbon sinks 3University of Miami scientist uncovers miscalculation in geological undersea record 2Gap junction protein vital to successful pregnancy, researchers find 2
(Date:11/25/2009)..., ,, BOCA RATON, Fla., Nov. 25 /PRNewswi...l year. Not so for BodyLogicMD. The nation,s larg...ns specializing exclusively in medically supervise... physicians in its network since November 20...s to add more physician-owned centers, including o...
(Date:11/25/2009)... Nov. 25 Ardea Bioscienc...ry D. Quart, Pharm.D., president and chief executi... Annual Health Care Conference. , ,Presentation d...Health Care Conference,Date: Tuesday, Decembe...on: The New York Palace Hotel, New York, NY,Webca...
(Date:11/24/2009)... The New York investment bank KTA Capital,s clie... an AU$6.7 mil convertible note private placement ...acement was arranged by KTA Capital as Neuren,s ex... New York (PRWEB) November 23, 2009 -...ital, LLC ("KTA Capital") has announced ...
(Date:11/24/2009)...S, Nov. 24 Sigma-Aldrich...t the NASDAQ OMX conference on Tuesday, December 1...ested parties may listen via live audio broadcast ...or.sig m a a ldrich.com/ . Users can click t...bout Sigma-Aldrich: Sigma-Aldrich is a leading L...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...g Research Institute Introduce New Research Base a... Diego , , SAN DIEGO, Feb. 11 Leading global bio...nd its affiliate Ferring Research Institute have o...ity located in Sorrento Valley, San Diego that wil...esearch and therapeutics. , , (Photo: http://w...
.... (OTC Bulletin Board: GOVX), an Atlanta-based, pu... human vaccines for diseases caused by HIV-1 (Huma...nts, today announced that Robert McNally, Ph.D., C...corporate update at the Eleventh Annual BIO CEO &a...Astoria Hotel, in New York. , , Dr. McNally prese...
...hronic Pain Indications , , LA JOLLA, Calif., Feb...TX ) today announced that oral administration of N...agonist, was safe and well-tolerated in healthy ma...ive consecutive days. , , "The successful complet... and tolerability of NGX426 when dosed over multip...
Other Biology Technology:Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix 2Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix 3Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix 4GeoVax Update Provided at the BIO CEO & Investor Conference 2009 2GeoVax Update Provided at the BIO CEO & Investor Conference 2009 3GeoVax Update Provided at the BIO CEO & Investor Conference 2009 4GeoVax Update Provided at the BIO CEO & Investor Conference 2009 5First Multiple Dose Clinical Trial of TorreyPines Therapeutics' Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated 2First Multiple Dose Clinical Trial of TorreyPines Therapeutics' Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated 3First Multiple Dose Clinical Trial of TorreyPines Therapeutics' Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated 4
Equine IL-4, Unconjugated from R&D Systems
DALT GRADIENT MAKER,230V from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-DLK1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...atch repair minus strains of E. coli. Use of these...unmethylated strand (1), leading to high mutation ...ms as the GeneEditor and Altered Sites II Mutagene...cA+, therefore inserts containing highly repetitiv...
Biology Products: